Implementation and Validation of the 2013 Caprini Score for Risk Stratification of Arthroplasty Patients in the Prevention of Venous Thrombosis

Overview

Journal Clin Appl Thromb Hemost

Publisher Sage Publications

Specialty Cardiology & Vascular Diseases

Date 2019 Apr 4

PMID 30939898

Citations 29

Authors

Eugene S Krauss

Ayal Segal

MaryAnne Cronin

Nancy Dengler

Martin L Lesser

Seungjun Ahn

Joseph A Caprini

Affiliations

Soon will be listed here.

Abstract

Appropriate chemoprophylaxis choice following arthroplasty requires accurate patient risk assessment. We compared the results of our prospective department protocol to the Caprini risk assessment model (RAM) retrospectively in this study group. Our goal was to determine whether the department protocol or the Caprini score would identify venous thromboembolism (VTE) events after total joint replacement. A secondary purpose was to validate the 2013 Caprini RAM in joint arthroplasty and determine whether patients with VTE would be accurately identified using the Caprini score. A total of 1078 patients met inclusion criteria. A Caprini score of 10 or greater is considered high risk and a score of 9 or less is considered low risk. The 2013 version of the Caprini RAM retrospectively stratified 7 of the 8 VTE events correctly, while only 1 VTE was identified with the prospective department protocol. This tool provided a consistent, accurate, and efficacious method for risk stratification and selection of chemoprophylaxis.

Citing Articles

The predicted value for venous thromboembolism based on a modified model of caprini combined with fasting blood glucose and D-dimer: a retrospective study.

Wang P, Yang Y, Zheng L, Qi X, Yan S, Dong H BMC Musculoskelet Disord. 2025; 26(1):130.

PMID: 39920615 PMC: 11806562. DOI: 10.1186/s12891-024-08133-2.

Caprini score combined with thrombotic molecular markers for predicting DVT in patients with traumatic fractures.

Wu Z, Du Y, Cai X, Xu Q Sci Rep. 2025; 15(1):1847.

PMID: 39805938 PMC: 11730296. DOI: 10.1038/s41598-025-85941-z.

Integrating D-Dimer Thresholds into the Revised Caprini Risk Stratification to Predict Deep Vein Thrombosis Risk in Preoperative Knee Osteoarthritis Patients.

Guo Y, Zhang D, Chen Y, Liu W, Gao N, Weng X Clin Appl Thromb Hemost. 2025; 31():10760296241311265.

PMID: 39784945 PMC: 11719442. DOI: 10.1177/10760296241311265.

Incidence, Risk Factors, and Modified Risk Assessment Model of Venous Thromboembolism in Non-Hodgkin Lymphoma Patients.

Li W, Liu R, Shen Y, Gao G, Yang R, Wang Y Cancer Med. 2024; 13(24):e70510.

PMID: 39711462 PMC: 11664237. DOI: 10.1002/cam4.70510.

Identifying high-risk groups for deep vein thrombosis after primary total knee arthroplasty using preoperative Caprini scores and D-dimer levels.

Qiao L, Yao Y, You X, Wu D, Tsai H, Zhou G J Orthop Surg Res. 2024; 19(1):616.

PMID: 39350206 PMC: 11443692. DOI: 10.1186/s13018-024-05074-3.

References

Youden W . Index for rating diagnostic tests. Cancer. 1950; 3(1):32-5. DOI: 10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3. View

Haddad T, Greeno E . Chemotherapy-induced thrombosis. Thromb Res. 2006; 118(5):555-68. DOI: 10.1016/j.thromres.2005.10.015. View

Beksac B, Gonzalez Della Valle A, Salvati E . Thromboembolic disease after total hip arthroplasty: who is at risk?. Clin Orthop Relat Res. 2006; 453:211-24. DOI: 10.1097/01.blo.0000238848.41670.41. View

Rocha A, de Vasconcellos A, da Luz Neto E, Araujo D, Alves E, Lopes A . Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery. Obes Surg. 2007; 16(12):1645-55. DOI: 10.1381/096089206779319383. View

Salvati E, Sharrock N, Westrich G, Potter H, Gonzalez Della Valle A, Sculco T . The 2007 ABJS Nicolas Andry Award: three decades of clinical, basic, and applied research on thromboembolic disease after THA: rationale and clinical results of a multimodal prophylaxis protocol. Clin Orthop Relat Res. 2007; 459:246-54. DOI: 10.1097/BLO.0b013e31805b7681. View

Geerts W, Bergqvist D, Pineo G, Heit J, Samama C, Lassen M . Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl):381S-453S. DOI: 10.1378/chest.08-0656. View

Johanson N, Lachiewicz P, Lieberman J, Lotke P, Parvizi J, Pellegrini V . Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg. 2009; 17(3):183-96. DOI: 10.5435/00124635-200903000-00007. View

Spinella P, Carroll C, Staff I, Gross R, Mc Quay J, Keibel L . Duration of red blood cell storage is associated with increased incidence of deep vein thrombosis and in hospital mortality in patients with traumatic injuries. Crit Care. 2009; 13(5):R151. PMC: 2784373. DOI: 10.1186/cc8050. View

Caprini J . Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg. 2010; 199(1 Suppl):S3-10. DOI: 10.1016/j.amjsurg.2009.10.006. View

10.

Amin A, Girard F, Samama M . Does ambulation modify venous thromboembolism risk in acutely ill medical patients?. Thromb Haemost. 2010; 104(5):955-61. DOI: 10.1160/TH10-04-0236. View

11.

. A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty. J Arthroplasty. 2011; 27(1):1-9.e2. DOI: 10.1016/j.arth.2011.03.032. View

12.

Gould M, Garcia D, Wren S, Karanicolas P, Arcelus J, Heit J . Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e227S-e277S. PMC: 3278061. DOI: 10.1378/chest.11-2297. View

13.

Falck-Ytter Y, Francis C, Johanson N, Curley C, Dahl O, Schulman S . Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e278S-e325S. PMC: 3278063. DOI: 10.1378/chest.11-2404. View

14.

Van Schouwenburg I, Mahmoodi B, Veeger N, Bakker S, Kluin-Nelemans H, Meijer K . Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study. J Thromb Haemost. 2012; 10(6):1012-8. DOI: 10.1111/j.1538-7836.2012.04707.x. View

15.

Pannucci C, Shanks A, Moote M, Bahl V, Cederna P, Naughton N . Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery. Ann Surg. 2012; 255(6):1093-9. PMC: 4496245. DOI: 10.1097/SLA.0b013e3182519ccf. View

16.

Vulcano E, Gesell M, Esposito A, Ma Y, Memtsoudis S, Gonzalez Della Valle A . Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol. Int Orthop. 2012; 36(10):1995-2002. PMC: 3460073. DOI: 10.1007/s00264-012-1588-4. View

17.

Enga K, Braekkan S, Hansen-Krone I, le Cessie S, Rosendaal F, Hansen J . Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study. J Thromb Haemost. 2012; 10(10):2068-74. DOI: 10.1111/j.1538-7836.2012.04880.x. View

18.

Khorana A, Dalal M, Lin J, Connolly G . Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer. 2012; 119(3):648-55. DOI: 10.1002/cncr.27772. View

19.

Zoller B, Ohlsson H, Sundquist J, Sundquist K . Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden. Thromb Haemost. 2013; 109(3):458-63. DOI: 10.1160/TH12-10-0743. View

20.

Sweetland S, Parkin L, Balkwill A, Green J, Reeves G, Beral V . Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study. Circulation. 2013; 127(12):1276-82. DOI: 10.1161/CIRCULATIONAHA.113.001428. View